Ramsay Health Care (RMY) Stock Forecast & Price Target
RMY Analyst Ratings
RMY Stock 12 Month Forecast
Average Price Target
CHF 30.52▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Low | UBS | CHF 32.46 | hold | ― | Reiterated | 10/29/26 | ||
| David Bailey | Morgan Stanley | CHF 24.46 | sell | ― | Reiterated | 10/27/26 | ||
 Unknown AnalystNot Ranked | Macquarie | CHF 31.64→CHF 32.46 | hold | ― | Downgraded | 10/19/26 | ||
| David Stanton | Jefferies | CHF 28.31→CHF 29.10 | hold | ― | Reiterated | 10/13/26 | ||
| Unknown AnalystNot Ranked | Ord Minnett | CHF 28.02 | sell | ― | Reiterated | 10/04/26 | ||
| Derek Jellinek | Morgans | CHF 28.83 | hold | ― | Reiterated | 09/23/26 | ||
| Craig Wong-Pan | RBC Capital | CHF 30.36→CHF 39.70 | buy | ― | Upgraded | 09/15/26 | ||
| Laura Sutcliffe | Citi | CHF 28.60 | hold | ― | Reiterated | 09/10/26 | ||
| Chris Cooper | J.P. Morgan | CHF 29.60 | hold | ― | Downgraded | 09/01/26 | ||
| Steven Wheen | Jarden | CHF 27.79→CHF 30.94 | buy | ― | Reiterated | 08/28/26 | ||
| Davinthra Thillainathan | Goldman Sachs | CHF 31.58 | buy | ― | Upgraded | 08/27/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Low | 10/29/26 | CHF 32.46 | hold | ― | Reiterated | UBS | ||
| David Bailey | 10/27/26 | CHF 24.46 | sell | ― | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 10/19/26 | CHF 31.64→CHF 32.46 | hold | ― | Downgraded | Macquarie | ||
| David Stanton | 10/13/26 | CHF 28.31→CHF 29.10 | hold | ― | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 10/04/26 | CHF 28.02 | sell | ― | Reiterated | Ord Minnett | ||
| Derek Jellinek | 09/23/26 | CHF 28.83 | hold | ― | Reiterated | Morgans | ||
| Craig Wong-Pan | 09/15/26 | CHF 30.36→CHF 39.70 | buy | ― | Upgraded | RBC Capital | ||
| Laura Sutcliffe | 09/10/26 | CHF 28.60 | hold | ― | Reiterated | Citi | ||
| Chris Cooper | 09/01/26 | CHF 29.60 | hold | ― | Downgraded | J.P. Morgan | ||
| Steven Wheen | 08/28/26 | CHF 27.79→CHF 30.94 | buy | ― | Reiterated | Jarden | ||
| Davinthra Thillainathan | 08/27/26 | CHF 31.58 | buy | ― | Upgraded | Goldman Sachs |
Best Analysts Covering Ramsay Health Care
Copying Steven Wheen's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +6.69% per trade.
Copying Steven Wheen's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of -3.07% per trade.
Copying Steven Wheen's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -8.87% per trade.
RMY Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 7 | 9 | 9 | 5 |
| Hold | 1 | 6 | 10 | 13 | 11 |
| Sell | 6 | 4 | 4 | 5 | 7 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 17 | 23 | 27 | 23 |
In the current month, RMY has received 5 Buy Ratings, 11 Hold Ratings, and 7 Sell Ratings. RMY average Analyst price target in the past 3 months is 30.52.
RMY Financial Forecast
RMY Earnings Forecast
Next quarter’s earnings estimate for RMY is CHF 0.43 with a range of CHF 0.35 to CHF 0.52. The previous quarter’s EPS was CHF 0.46. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RMY Sales Forecast
Next quarter’s sales forecast for RMY is CHF 5.41B with a range of CHF 5.35B to CHF 5.48B. The previous quarter’s sales results were CHF 5.35B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
